AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,728,402 | -31.8% | 944,505 | +9.2% | 0.00% | -33.3% |
| Q2 2023 | $14,256,765 | +121.6% | 865,095 | +23.2% | 0.00% | +50.0% |
| Q1 2023 | $6,432,894 | -19.6% | 702,281 | -37.1% | 0.00% | +100.0% |
| Q4 2022 | $7,997,699 | +51.5% | 1,116,997 | +6.0% | 0.00% | 0.0% |
| Q3 2022 | $5,278,000 | +100.5% | 1,053,520 | -2.4% | 0.00% | – |
| Q2 2022 | $2,633,000 | -19.2% | 1,078,962 | +126.3% | 0.00% | – |
| Q1 2022 | $3,257,000 | -2.8% | 476,797 | +15.0% | 0.00% | – |
| Q4 2021 | $3,350,000 | +37.5% | 414,576 | +66.8% | 0.00% | – |
| Q3 2021 | $2,436,000 | +48.0% | 248,587 | +1.7% | 0.00% | – |
| Q2 2021 | $1,646,000 | -28.5% | 244,509 | -4.0% | 0.00% | – |
| Q1 2021 | $2,302,000 | +89.5% | 254,667 | +40.1% | 0.00% | – |
| Q4 2020 | $1,215,000 | -3.0% | 181,811 | -26.8% | 0.00% | – |
| Q3 2020 | $1,252,000 | +1.5% | 248,420 | +62.7% | 0.00% | – |
| Q2 2020 | $1,234,000 | -22.5% | 152,673 | -23.8% | 0.00% | -100.0% |
| Q1 2020 | $1,592,000 | -3.4% | 200,414 | -8.2% | 0.00% | – |
| Q4 2019 | $1,648,000 | +663.0% | 218,258 | +318.6% | 0.00% | – |
| Q3 2019 | $216,000 | +39.4% | 52,136 | -3.3% | 0.00% | – |
| Q2 2019 | $155,000 | -38.0% | 53,903 | -44.4% | 0.00% | – |
| Q4 2018 | $250,000 | -64.3% | 96,885 | -39.3% | 0.00% | – |
| Q3 2018 | $701,000 | -60.6% | 159,540 | -45.0% | 0.00% | -100.0% |
| Q2 2018 | $1,777,000 | +43.5% | 289,891 | +70.7% | 0.00% | – |
| Q1 2018 | $1,238,000 | -8.5% | 169,851 | +2.9% | 0.00% | -100.0% |
| Q4 2017 | $1,353,000 | +20.9% | 165,075 | +54.9% | 0.00% | 0.0% |
| Q3 2017 | $1,119,000 | +216.1% | 106,569 | +232.2% | 0.00% | – |
| Q2 2017 | $354,000 | – | 32,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,498,838 | $22,889,355 | 11.72% |
| Knoll Capital Management, LLC | 500,000 | $4,580,000 | 7.06% |
| GENDELL JEFFREY L | 5,301,914 | $48,565,532 | 4.55% |
| COWEN AND COMPANY, LLC | 3,732,778 | $34,192,246 | 4.02% |
| Tri Locum Partners LP | 1,327,097 | $12,156,209 | 3.70% |
| Samsara BioCapital, LLC | 1,409,409 | $12,910,186 | 2.67% |
| Altium Capital Management LP | 500,000 | $4,580,000 | 2.54% |
| Vivo Capital, LLC | 3,761,438 | $34,454,772 | 2.39% |
| RTW INVESTMENTS, LP | 5,741,939 | $52,596,161 | 1.10% |
| Knott David M Jr | 291,113 | $2,667 | 1.05% |